Hui Liu

Hui Liu is a Chief Technology Officer at Matinas BioPharma Holdings, Inc. He previously worked as a Director-Formulation & Delivery at Seqirus USA, Inc. and as a CMC Director at Cellics Therapeutics, Inc. Liu holds a doctorate from the University of Michigan, an undergraduate degree from the University of Science & Technology of China, and an MBA from the University of Massachusetts Amherst.